Articles by Andrea Antinori

1 2 3 4 5

Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study

van Lunzen, Jan; Antinori, Andrea; Cohen, Calvin J.; More

AIDS. 30(2):251-259, January 2016.

Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly ...

Pinnetti, Carmela; Tintoni, Mauro; Ammassari, Adriana; More

AIDS. 29(18):2534-2537, November 28th, 2015.

Week 48 efficacy and central nervous system analysis of darunavir/ritonavir monotherapy versus darunavir/ritonavir with two nucleoside analogues

Antinori, Andrea; Clarke, Amanda; Svedhem-Johansson, Veronika; More

AIDS. 29(14):1811-1820, September 10, 2015.

Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression: 48-week efficacy and safety results

Castagna, Antonella; Spagnuolo, Vincenzo; Galli, Laura; More

AIDS. 28(15):2269-2279, September 24th, 2014.

Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment

Lapadula, Giuseppe; Cozzi-Lepri, Alessandro; Marchetti, Giulia; More

AIDS. 27(5):769-779, March 13th, 2013.

Polyclonal serum-free light chains elevation in HIV-infected patients

Bibas, Michele; Lorenzini, Patrizia; Cozzi-Lepri, Alessandro; More

AIDS. 26(16):2107-2110, October 23rd, 2012.

Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count

Marchetti, Giulia; Cozzi-Lepri, Alessandro; Merlini, Esther; More

AIDS. 25(11):1385-1394, July 17th, 2011.

Patients presenting with AIDS in the HAART era: a collaborative cohort analysis

Mussini, Cristina; Manzardo, Christian; Johnson, Margaret; More

AIDS. 22(18):2461-2469, November 30th, 2008.

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis

De Luca, Andrea; Ammassari, Adriana; Pezzotti, Patrizio; More

AIDS. 22(14):1759-1767, September 12th, 2008.

Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients

Zaccarelli, Mauro; Tozzi, Valerio; Lorenzini, Patrizia; More

AIDS. 19(10):1081-1089, July 1st, 2005.

Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure

Ceccherini-Silberstein, Francesca; Erba, Fulvio; Gago, Federico; More

AIDS. 18(12):11-19, August 20th, 2004.

Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving...

Trotta, Maria Paola; Ammassari, Adriana; Cozzi-Lepri, Alessandro; More

AIDS. 17(7):1099-1102, May 2nd, 2003.

Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients

Antinori, Andrea; Giancola, Maria Letizia; Grisetti, Susanna; More

AIDS. 16(14):1867-1876, September 27th, 2002.

Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/μl

Mussini, Cristina; Bugarini, Roberto; Perno, Carlo Federico; More

AIDS. 16(11):1551-1554, July 26th, 2002.

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)

Cingolani, Antonella; Antinori, Andrea; Rizzo, Maria Gabriella; More

AIDS. 16(3):369-379, February 15th, 2002.

Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy

Antinori, Andrea; Cingolani, Antonella; Alba, Lucia; More

AIDS. 15(12):1483-1491, August 17th, 2001.

Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy

Antinori, Andrea; Baldini, Francesco; Girardi, Enrico; More

AIDS. 15(12):1579-1581, August 17th, 2001.

When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study

Lepri, Alessandro Cozzi; Phillips, Andrew N.; d'Arminio Monforte, Antonella; More

AIDS. 15(8):983-990, May 25th, 2001.

Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy

De Luca, Andrea; Giancola, Maria Letizia; Ammassari, Adriana; More

AIDS. 14(14):F117-F121, September 29th, 2000.

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients

Monforte, Antonella d'Arminio; Lepri, Alessandro Cozzi; Rezza, Giovanni; More

AIDS. 14(5):499-507, March 31st, 2000.

Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults

Pontesilli, Oscar; Guerra, Emma C.; Ammassari, Adriana; More

AIDS. 12(5):473-480, March 26th, 1998.

Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis

Antinori, Andrea; Murri, Rita; Ammassari, Adriana; More

AIDS. 9(12):1343-1350, December 1995.

1 2 3 4 5